Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells (Q42457924)
Jump to navigation
Jump to search
scientific article published on July 1998
- Calcium/Calmodulin Kinase Inhibitors and Immunosuppressant Macrolides Rapamycin and FK506 Inhibit Progestin- and Glucocorticosteroid Receptor-Mediated Transcription in Human Breast Cancer T47D Cells
Language | Label | Description | Also known as |
---|---|---|---|
English | Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells |
scientific article published on July 1998 |
|
Statements
1 reference
Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells (English)
1 reference
Calcium/Calmodulin Kinase Inhibitors and Immunosuppressant Macrolides Rapamycin and FK506 Inhibit Progestin- and Glucocorticosteroid Receptor-Mediated Transcription in Human Breast Cancer T47D Cells (English)
0 references
Le Bihan S
1 reference
Marsaud V
1 reference
Mercier-Bodard C
1 reference
Baulieu EE
1 reference
Mader S
1 reference
White JH
1 reference
Renoir JM
1 reference
1 July 1998
1 reference
July 1998
0 references
1 reference
12
1 reference
7
1 reference
986-1001
1 reference
Identifiers
1 reference
1 reference